H-1B sponsorship profile: Carsgen Therapeutics Corporation. Across U.S. Department of Labor LCA disclosures, Carsgen Therapeutics Corporation filed 8 Labor Condition Applications covering 8 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 87.5% (7 certified of 8 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Carsgen Therapeutics Corporation’s H-1B petitions range from $122,740 at the low end to $177,600 at the high end, with a petition-weighted average of $134,234. That range reflects the mix of occupations the company sponsors, led by Senior Clinical Scientist (3 petitions at $130,100 avg), followed by LEAD SCIENTIST/CLINICAL DATA MANAGEMENT and MSAT Assistant Director. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Carsgen Therapeutics Corporation is headquartered in Durham, NC under NAICS code 32541, and places H-1B workers across 3 states, most heavily in NC, OH, TX. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Carsgen Therapeutics Corporation ranks. By H-1B petition volume, Carsgen Therapeutics Corporation is #19,368 of 119,880 employers nationally and #509 of 2,377 employers headquartered in NC. Both ranks are computed live from the same underlying petition counts, not a separate estimate.